Overview

A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)

Status:
Suspended
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
A pharmacokinetic study on the absorption of perorally delivered insulin in dextran matrix after single dose administration.
Phase:
Phase 1
Details
Lead Sponsor:
Bows Pharmaceuticals AG
Treatments:
Dextrans
Insulin
Insulin, Globin Zinc